Figure
6 In vivo testing and analysis of lead compound to understand
its efficiency and toxicity in a mouse model. The lead compound to be
validated is injected into a mouse infected with COVID-19. This mouse is
then observed for any changes in the disease condition. If the mouse
shows an improvement in the disease outcome, then the drug injected is
considered for further evaluation through human trials.